Sign up for newsletters
Stay up to date on the weekly newsletters on recent news and activities.
12.10.2026 - Economy, Healthcare, Innovation
This week brings several significant developments for Latvia’s economy. Following the elections, economic growth is emerging as one of the key issues on the political agenda, while the business sector is seeing opportunities for innovation and new investment. These developments highlight the importance of creating an environment in which Latvian companies can grow, invest, export, and increasingly develop high-value-added products and services.
On 3 October, Latvian citizens made their choice by electing a new Saeima. One of the key signals emerging after the elections is that economic growth is taking centre stage on the political agenda. It was also one of the most prominent topics in pre-election discussions.
However, setting priorities is not enough. It must be followed by concrete action. For Latvia’s economy to grow, businesses must have the opportunity to develop, export, and attract investment, while the public administration must be able to reduce barriers that hinder entrepreneurship.
That is why removing barriers to exports, attracting investment to Latvia, and reducing bureaucracy will be particularly important priorities for the next Saeima and government. These are not merely business environment issues. They directly affect economic growth, job creation, productivity, and people’s prosperity.
Moreover, the more favourable the conditions for economic development, the greater the benefits for society as a whole. These include tax revenues that can be used to fund a wide range of public needs, from road infrastructure and healthcare to teachers’ salaries and much more.
Latvia ranks 40th out of 139 countries and economies in the 2026 Global Innovation Index, climbing one place over the past year. The index data highlights the country’s considerable potential in innovation, creativity, and digital development.
Latvia’s strengths include the creative industries, digital creativity, and intellectual property creation. Positive momentum can also be seen in the patent sector, with Latvia already ranking among the world’s leaders in certain indicators.
Innovation creates the conditions for businesses to develop higher-value-added products and services, expand exports, and strengthen their competitiveness in international markets. Latvian companies already provide examples of this potential in practice.
At the same time, the index highlights a significant challenge: Latvia invests more in innovation than it manages to translate into tangible results.
It is therefore important not only to increase investment in innovation but also to generate greater economic returns from it. This requires stronger cooperation between businesses and research institutions, the commercialisation of research results, and more effective conversion of knowledge into high-value-added products and services.
Latvia’s pharmaceutical sector continues to adapt to changes in the medicines market and increasingly complex international supply chains. Against this backdrop, AS Recipe plus has announced a significant €20 million investment in a new automated logistics centre for medicines and medical supplies in Riga.
The investment will increase warehouse capacity, automate goods handling, and make deliveries more efficient and secure.
The company’s development comes at a time when operating conditions in the pharmaceutical market have changed considerably. Reforms to medicine pricing, geopolitical risks, and volatility in international supply chains are prompting companies across the sector to seek more efficient and sustainable operating models.
The investment is also significant in the broader context of Latvia’s economy and security. The supply of medicines is a strategically important part of the country’s infrastructure, and its reliability is essential for both the population and the healthcare system.
Investments by locally owned companies in developing this infrastructure strengthen Latvia’s ability to ensure the uninterrupted availability of medicines and medical supplies, including when external supply chains face disruptions.
Source: lsm.lv
Stay up to date on the weekly newsletters on recent news and activities.
Stay up to date on the weekly newsletters on recent news and activities.